Kate Haviland - Net Worth and Insider Trading
Kate Haviland Net Worth
The estimated net worth of Kate Haviland is at least $13 Million dollars as of 2024-12-28. Kate Haviland is the CHIEF EXECUTIVE OFFICER of Blueprint Medicines Corp and owns about 150,824 shares of Blueprint Medicines Corp (BPMC) stock worth over $13 Million. Details can be seen in Kate Haviland's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kate Haviland has not made any transactions after 2024-11-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kate Haviland
Kate Haviland Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kate Haviland owns 2 companies in total, including Blueprint Medicines Corp (BPMC) , and Fulcrum Therapeutics Inc (FULC) .
Click here to see the complete history of Kate Haviland’s form 4 insider trades.
Insider Ownership Summary of Kate Haviland
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BPMC | Blueprint Medicines Corp | 2024-11-29 | Chief Business Officer |
| FULC | Fulcrum Therapeutics Inc | 2020-06-11 | director |
Kate Haviland Latest Holdings Summary
Kate Haviland currently owns a total of 1 stock. Kate Haviland owns 150,824 shares of Blueprint Medicines Corp (BPMC) as of November 29, 2024, with a value of $13 Million.
Latest Holdings of Kate Haviland
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BPMC | Blueprint Medicines Corp | 2024-11-29 | 150,824 | 89.40 | 13,483,666 |
Holding Weightings of Kate Haviland
Kate Haviland Form 4 Trading Tracker
According to the SEC Form 4 filings, Kate Haviland has made a total of 14 transactions in Blueprint Medicines Corp (BPMC) over the past 5 years, including 1 buys and 13 sells. The most-recent trade in Blueprint Medicines Corp is the sale of 2,353 shares on November 29, 2024, which brought Kate Haviland around $227,300.
Insider Trading History of Kate Haviland
- 1
Kate Haviland Trading Performance
GuruFocus tracks the stock performance after each of Kate Haviland's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kate Haviland is 3.82%. GuruFocus also compares Kate Haviland's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kate Haviland within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kate Haviland's insider trading performs compared to the benchmark.
Performance of Kate Haviland
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.28 | | | | | |
| Relative Return to S&P 500(%) | 1.82 | | | | | |
Kate Haviland Ownership Network
Kate Haviland Owned Company Details
What does Blueprint Medicines Corp do?
Who are the key executives at Blueprint Medicines Corp?
Kate Haviland is the Chief Business Officer of Blueprint Medicines Corp. Other key executives at Blueprint Medicines Corp include director & CEO & President Jeffrey W. Albers , Chief Commercial Officer Christina Rossi , and Principal Accounting Officer Ariel Hurley .
Blueprint Medicines Corp (BPMC) Insider Trades Summary
Over the past 18 months, Kate Haviland made no insider transaction in Blueprint Medicines Corp (BPMC). Other recent insider transactions involving Blueprint Medicines Corp (BPMC) include a net sale of 185,808 shares made by Jeffrey W. Albers , a net sale of 16,234 shares made by Ariel Hurley , and a net sale of 38,146 shares made by Michael Landsittel .
In summary, during the past 3 months, insiders sold 52,177 shares of Blueprint Medicines Corp (BPMC) in total and bought 0 shares, with a net sale of 52,177 shares. During the past 18 months, 509,699 shares of Blueprint Medicines Corp (BPMC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 509,699 shares.
Blueprint Medicines Corp (BPMC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Blueprint Medicines Corp Insider Transactions
Kate Haviland Mailing Address
Above is the net worth, insider trading, and ownership report for Kate Haviland. You might contact Kate Haviland via mailing address: Blueprint Medicines Corporation, 38 Sidney Street, Suite 200, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
